| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
MEMO TO THE MEDIA |
Press Release
PSA Is Poor Predictor of Lethal Prostate Cancer
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
| The first 10% of the full text of this article appears below. |
The amount of prostate-specific antigen (PSA) in a man's bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer, according to a study in the April 4 Journal of the National Cancer Institute.
Although men with untreated localized prostate cancer have
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 496-497.
J Natl Cancer Inst 2007 99: 526-532.